- Wellness company Wellfully (WFL) has successfully had its Swisswell knee patch registered as a medical device in Australia by the Therapeutic Good Administration (TGA)
- This follows approvals of the knee patch as a medical device in the United States and Europe in April
- The knee patch purportedly helps with inflamed joints and joint function using Wellfully’s diamagnetic micro-array technology
- Wellfully launched the Swisswell knee patch a year ago but only sold the product through its direct-to-consumer channels without any formal registration or medical claims
- Wellfully shares are trading grey at 3.8 cents at 3:28 pm AEST
Wellness company Wellfully (WFL) has successfully had its Swisswell knee patch registered as a medical device in Australia by the Therapeutic Goods Administration (TGA).
The Australian approval follows the knee patch’s registration in the United States by the Food and Drug Administration (FDA) and its registration as a medical device in the European Union in April.
The company says this latest registration will allow it to “freely engage with retail partners and specialist distributors in the Australian market”.
On Wellfully’s website, CEO Paul Peros said the knee patch helped with inflamed joints and joint function and was “embedded with Wellfully’s proprietary diamagnetic micro-array technology that helps push the active molecules contained in the formula deep through the skin barrier and into the tissue around the knee.”
Wellfully launched the Swisswell knee patch a year ago but only sold the product through its direct-to-consumer channels without any formal registration or medical claims.
The company said consumer and potential distribution partner feedback had so far been “most positive”.
Wellfully shares were trading grey at 3.8 cents at 3:28 pm AEST.